SenesTech, Inc.
SNESOther · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $2.2M | $1.9M | $1.2M | $1.0M | $600,000 | $282,000 |
| Operating income | −$6.5M | −$6.2M | −$7.7M | −$9.7M | −$8.9M | −$7.9M |
| Net income | −$6.4M | −$6.2M | −$7.7M | −$9.7M | −$8.3M | −$8.4M |
| Total assets | $12.8M | $3.3M | $7.3M | $6.8M | $11.5M | $6.0M |
| Total liabilities | $3.3M | $767,000 | $942,000 | $1.5M | $1.5M | $2.1M |
| Equity | $9.6M | $2.5M | $6.4M | $5.3M | $10.0M | $3.9M |
| EPS (diluted) | $-1.95 | $-8.86 | $-115.10 | $-148.08 | $-14.77 | — |
| Shares out. | 1.7M | 5.1M | 2.1M | 12.2M | 12.2M | 1.8M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −292.9%
- Net margin
- −287.4%
- Return on equity
- −66.7%
- Return on assets
- −49.7%
- Return on capital (ROCE)
- −54.0%
- Liabilities / assets
- 25.5%
- Debt / equity
- 0.34×
- Book value / share
- $5.48
- Revenue growth (YoY)
- 19.6%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -31.77distress
- Accruals / assets
- −4.9%clean
- Beneish M-Score
- 0.74elevated
- Piotroski F-Score
- 5/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 1 severe● 4 warning● 3 good- Altman Z″ in the distress zone
- Operating losses (negative operating margin)
- Reported a net loss
- Negative operating cash flow
- Beneish M-Score elevated — earnings-manipulation screen flag
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Glenbrook Capital ManagementPassive (13G)Mar 18, 2026
- Pfs Cap Mgt CoPassive (13G)Aug 12, 2025
- Lind Global Fund Ii LpPassive (13G)May 15, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Glenbrook Capital Management10% owner | May 14, 2026 | Buy | 15,000 | $1.72 |
| Edell MichaelOfficer — Chief Executive Officer | May 14, 2026 | Buy | 2,000 | $1.70 |
| Glenbrook Capital Management10% owner | Apr 28, 2026 | Buy | 3,000 | $1.47 |
| Glenbrook Capital Management10% owner | Mar 13, 2026 | Buy | 146,249 | $1.95 |
| Glenbrook Capital Management10% owner | Feb 17, 2026 | Buy | 40,807 | $2.29 |
| Glenbrook Capital Management10% owner | Feb 11, 2026 | Buy | 8,000 | $1.73 |
| Glenbrook Capital Management10% owner | Feb 4, 2026 | Buy | 5,685 | $1.82 |
| Glenbrook Capital Management10% owner | Jan 30, 2026 | Buy | 5,399 | $1.87 |
| Leach Jacob StevenDirector | Nov 18, 2025 | Sell | 62 | $2.71 |
| Szot Matthew KDirector | Nov 14, 2025 | Sell | 1 | $2.75 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 92,345 | 1.0 | +289.5% |
| Apr 30, 2026 | 23,711 | 1.1 | -23.6% |
| Apr 15, 2026 | 31,028 | 1.4 | +59.2% |
| Mar 31, 2026 | 19,492 | 1.0 | -30.0% |
| Mar 13, 2026 | 27,834 | 1.0 | -43.7% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Results of operationsMay 12, 2026
- Director / officer changeMay 7, 2026
- Results of operationsMar 12, 2026
- Director / officer changeJan 28, 2026
- Director / officer changeNov 14, 2025
- Results of operationsNov 10, 2025
- Director / officer changeOct 21, 2025
- Other material eventSep 24, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.